The CDK2 inhibitor INCB123667 showed positive efficacy and safety signals in platinum-resistant/refractory ovarian cancer.

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

Maya Ortiz of North Reading is organizing “Trotting In Teal,” an awareness/fundraising event for ovarian cancer that will be ...

Genetic testing revealed that she was positive for BRCA1, a genetic mutation that increases one’s risk of breast and ovarian ...

Delta passengers were stranded on a tiny island in the middle of the Atlantic for 29 hours after midair engine trouble ...

Ovarian cancer often goes undetected until advanced stages. Emerging tools like liquid biopsies and AI offer hope, but ...

New research reveals PD-L1 expression enhances survival in advanced ovarian cancer, linking it to homologous recombination ...

A groundbreaking new therapy for ovarian cancer is being trialled on a Brisbane woman, in an Australian-first, which aims to ...

A doctor has shared five symptoms of a type of cancer she says 'everyone' should know, as it can be 'difficult to detect' if ...

Cancer can often be difficult to detect in the early stages, particularly if it is a more 'subtle' form of the disease. So ...

Disease-free and overall survival were comparable between paclitaxel- and cisplatin-based heated chemotherapy regimens in ...

Fat tissue secretes hormones known as adipokines. Patients with obesity have a larger amount of leptin than a normal ...